FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16182011000001109: Fosavance tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57123201000001112 Fosavance tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57123301000001115 Fosavance tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fosavance tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Is a Alendronic acid 70mg / Colecalciferol 70microgram tablets true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has active ingredient Colecalciferol true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has active ingredient Alendronate true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has specific active ingredient Colecalciferol true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has specific active ingredient Alendronate sodium true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alendronic acid true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Is a Fosavance true Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Fosavance tablets (Lexon (UK) Ltd) Has basis of strength substance Alendronic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Fosavance tablets (Lexon (UK) Ltd) 4 tablet Has AMP True Fosavance tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start